Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03918356 · ClinicalTrials.gov registry record · NA
Application of Electrical Impedance Myography (EIM) as a Potential Biomarker of Idiopathic Inflammatory Myopathies
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03918356 is a NA study that has completed, run by Yale University. The registered enrollment target is 5 participants.
The verdict
NCT03918356, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
1. To assess changes in impedance parameters in Idiopathic Inflammatory Myopathies (IIMs). 2. To assess whether EIM parameters are reflective of disease severity, based on clinical outcome measures of IIMs.
Interventions
- DEVICE electrical impedance myography
- OTHER healthy control group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2021-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03918356
The ClinicalTrials.gov registry entry for NCT03918356 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which electrical impedance myography is the first listed.
NCT03918356 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03918356 about?
NCT03918356 is a clinical study titled "Application of Electrical Impedance Myography (EIM) as a Potential Biomarker of Idiopathic Inflammatory Myopathies". 1. To assess changes in impedance parameters in Idiopathic Inflammatory Myopathies (IIMs). 2. To assess whether EIM parameters are reflective of disease severity, based on clinical outcome measures of IIMs.
What is the current status of trial NCT03918356?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2019-06-01. Estimated completion is 2021-05-30.
What interventions are being tested in trial NCT03918356?
The interventions under investigation include: electrical impedance myography (DEVICE), healthy control group (OTHER).
Who is sponsoring clinical trial NCT03918356?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.